Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (51-60 of 336) with videos related to

Pageof 34
Sort By:
Clinical Chemistry|January 4, 2024
Breast Cancer Circulating Tumor Cells: Current Clinical Applications and Future ProspectsAndi K Cani, Daniel F Hayes
JCO Precision Oncology|February 17, 2022
Delivery of Personalized Medicine With PrecisionDaniel F Hayes, Julie M Vose
Progress in Molecular Biology and Translational Science|November 16, 2010
Circulating tumor cellsDaniel F Hayes, Jeffrey B Smerage
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Chemotherapy: What Are the Benefits for the Patient and for the Investigator?Daniel F Hayes, Anne F Schott
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Assessing the measure of a new drug: is survival the only thing that matters?Daniel J Sargent, Daniel F Hayes
Oncology (Williston Park, N.Y.)|December 18, 2007
Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancerN Lynn Henry, Daniel F Hayes
The Oncologist|June 24, 2006
Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancerN Lynn Henry, Daniel F Hayes
The Oncologist|March 13, 2020
Completing the TranslationRobert T McCormack, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2019
Pharmacogenomics and Endocrine Therapy in Breast CancerDaniel F Hayes, James M Rae
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Defining the benefits of neoadjuvant chemotherapy for breast cancerAnne F Schott, Daniel F Hayes
Pageof 34

Showing results (51-60 of 336) with videos related to

Sort By:
Pageof 34
Clinical Chemistry|January 4, 2024
Breast Cancer Circulating Tumor Cells: Current Clinical Applications and Future ProspectsAndi K Cani, Daniel F Hayes
JCO Precision Oncology|February 17, 2022
Delivery of Personalized Medicine With PrecisionDaniel F Hayes, Julie M Vose
Progress in Molecular Biology and Translational Science|November 16, 2010
Circulating tumor cellsDaniel F Hayes, Jeffrey B Smerage
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Chemotherapy: What Are the Benefits for the Patient and for the Investigator?Daniel F Hayes, Anne F Schott
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Assessing the measure of a new drug: is survival the only thing that matters?Daniel J Sargent, Daniel F Hayes
Oncology (Williston Park, N.Y.)|December 18, 2007
Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancerN Lynn Henry, Daniel F Hayes
The Oncologist|June 24, 2006
Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancerN Lynn Henry, Daniel F Hayes
The Oncologist|March 13, 2020
Completing the TranslationRobert T McCormack, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2019
Pharmacogenomics and Endocrine Therapy in Breast CancerDaniel F Hayes, James M Rae
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Defining the benefits of neoadjuvant chemotherapy for breast cancerAnne F Schott, Daniel F Hayes
Pageof 34